Influenza Therapeutics Market Report

Global and Region Influenza Therapeutics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：154
  • REPORT CODE：GMM970725
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Influenza Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Influenza Therapeuticsmarket, defines the market attractiveness level of Influenza Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Influenza Therapeutics industry, describes the types of Influenza Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Influenza Therapeutics market and the development prospects and opportunities of Influenza Therapeutics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Influenza Therapeutics market in Chapter 13.

    By Player:

    • BiondVax Pharmaceuticals Ltd

    • GlaxoSmithKline plc

    • Natco Pharma

    • GE Healthcare Life Sciences

    • Atriva Therapeutics Gmbh

    • Daiichi Sankyo Company

    • Mylan, Inc

    • F Hoffmann-La Roche Ltd

    • Sandoz International GmbH (Novartis AG)

    • Sanofi Pasteur SA

    • Texas Medical Center

    • Teva Pharmaceutical Industries Ltd

    • Sun Pharmaceutical Industries Ltd

    • Life Science Austria (LISA)

    By Type:

    • Vaccines

    • Drugs

    By End-User:

    • Hospitals

    • Clinics

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Influenza Therapeutics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Influenza Therapeutics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Influenza Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Influenza Therapeutics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Influenza Therapeutics Market Analysis and Outlook to 2022

    • 7.1 Global Influenza Therapeutics Consumption (2017-2022)

    • 7.2 United States Influenza Therapeutics Consumption (2017-2022)

    • 7.3 Europe Influenza Therapeutics Consumption (2017-2022)

    • 7.4 China Influenza Therapeutics Consumption (2017-2022)

    • 7.5 Japan Influenza Therapeutics Consumption (2017-2022)

    • 7.6 India Influenza Therapeutics Consumption (2017-2022)

    • 7.7 South Korea Influenza Therapeutics Consumption (2017-2022)

    8 Region and Country-wise Influenza Therapeutics Market Analysis and Outlook to 2028

    • 8.1 Global Influenza Therapeutics Consumption Forecast (2022-2028)

    • 8.2 United States Influenza Therapeutics Consumption Forecast (2022-2028)

    • 8.3 Europe Influenza Therapeutics Consumption Forecast (2022-2028)

    • 8.4 China Influenza Therapeutics Consumption Forecast (2022-2028)

    • 8.5 Japan Influenza Therapeutics Consumption Forecast (2022-2028)

    • 8.6 India Influenza Therapeutics Consumption Forecast (2022-2028)

    • 8.7 South Korea Influenza Therapeutics Consumption Forecast (2022-2028)

    9 Global Influenza Therapeutics Market Outlook by Types and Applications to 2022

    • 9.1 Global Influenza Therapeutics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Vaccines Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Influenza Therapeutics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Influenza Therapeutics Market Outlook by Types and Applications to 2028

    • 10.1 Global Influenza Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Influenza Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Influenza Therapeutics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Influenza Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Influenza Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Influenza Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Influenza Therapeutics Market Competitive Analysis

    • 14.1 BiondVax Pharmaceuticals Ltd

      • 14.1.1 BiondVax Pharmaceuticals Ltd Company Details

      • 14.1.2 BiondVax Pharmaceuticals Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 BiondVax Pharmaceuticals Ltd Influenza Therapeutics Product and Service

    • 14.2 GlaxoSmithKline plc

      • 14.2.1 GlaxoSmithKline plc Company Details

      • 14.2.2 GlaxoSmithKline plc Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 GlaxoSmithKline plc Influenza Therapeutics Product and Service

    • 14.3 Natco Pharma

      • 14.3.1 Natco Pharma Company Details

      • 14.3.2 Natco Pharma Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Natco Pharma Influenza Therapeutics Product and Service

    • 14.4 GE Healthcare Life Sciences

      • 14.4.1 GE Healthcare Life Sciences Company Details

      • 14.4.2 GE Healthcare Life Sciences Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 GE Healthcare Life Sciences Influenza Therapeutics Product and Service

    • 14.5 Atriva Therapeutics Gmbh

      • 14.5.1 Atriva Therapeutics Gmbh Company Details

      • 14.5.2 Atriva Therapeutics Gmbh Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Atriva Therapeutics Gmbh Influenza Therapeutics Product and Service

    • 14.6 Daiichi Sankyo Company

      • 14.6.1 Daiichi Sankyo Company Company Details

      • 14.6.2 Daiichi Sankyo Company Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Daiichi Sankyo Company Influenza Therapeutics Product and Service

    • 14.7 Mylan, Inc

      • 14.7.1 Mylan, Inc Company Details

      • 14.7.2 Mylan, Inc Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Mylan, Inc Influenza Therapeutics Product and Service

    • 14.8 F Hoffmann-La Roche Ltd

      • 14.8.1 F Hoffmann-La Roche Ltd Company Details

      • 14.8.2 F Hoffmann-La Roche Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 F Hoffmann-La Roche Ltd Influenza Therapeutics Product and Service

    • 14.9 Sandoz International GmbH (Novartis AG)

      • 14.9.1 Sandoz International GmbH (Novartis AG) Company Details

      • 14.9.2 Sandoz International GmbH (Novartis AG) Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Sandoz International GmbH (Novartis AG) Influenza Therapeutics Product and Service

    • 14.10 Sanofi Pasteur SA

      • 14.10.1 Sanofi Pasteur SA Company Details

      • 14.10.2 Sanofi Pasteur SA Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi Pasteur SA Influenza Therapeutics Product and Service

    • 14.11 Texas Medical Center

      • 14.11.1 Texas Medical Center Company Details

      • 14.11.2 Texas Medical Center Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Texas Medical Center Influenza Therapeutics Product and Service

    • 14.12 Teva Pharmaceutical Industries Ltd

      • 14.12.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.12.2 Teva Pharmaceutical Industries Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Teva Pharmaceutical Industries Ltd Influenza Therapeutics Product and Service

    • 14.13 Sun Pharmaceutical Industries Ltd

      • 14.13.1 Sun Pharmaceutical Industries Ltd Company Details

      • 14.13.2 Sun Pharmaceutical Industries Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Sun Pharmaceutical Industries Ltd Influenza Therapeutics Product and Service

    • 14.14 Life Science Austria (LISA)

      • 14.14.1 Life Science Austria (LISA) Company Details

      • 14.14.2 Life Science Austria (LISA) Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Life Science Austria (LISA) Influenza Therapeutics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Influenza Therapeutics

    • Figure Influenza Therapeutics Picture

    • Table Global Influenza Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Therapeutics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Influenza Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Influenza Therapeutics Consumption by Country (2017-2022)

    • Figure United States Influenza Therapeutics Consumption and Growth Rate (2017-2022)

    • Table Europe Influenza Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure China Influenza Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Japan Influenza Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure India Influenza Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Influenza Therapeutics Consumption and Growth Rate (2017-2022)

    • Figure Global Influenza Therapeutics Consumption Forecast by Country (2022-2028)

    • Figure United States Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Influenza Therapeutics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vaccines Consumption and Growth Rate (2017-2022)

    • Figure Global Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Vaccines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Influenza Therapeutics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Influenza Therapeutics Export by Region (Top 5 Countries) (2017-2028)

    • Table BiondVax Pharmaceuticals Ltd (Foundation Year, Company Profile and etc.)

    • Table BiondVax Pharmaceuticals Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table BiondVax Pharmaceuticals Ltd Influenza Therapeutics Product and Service

    • Table GlaxoSmithKline plc (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline plc Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Influenza Therapeutics Product and Service

    • Table Natco Pharma (Foundation Year, Company Profile and etc.)

    • Table Natco Pharma Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Natco Pharma Influenza Therapeutics Product and Service

    • Table GE Healthcare Life Sciences (Foundation Year, Company Profile and etc.)

    • Table GE Healthcare Life Sciences Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table GE Healthcare Life Sciences Influenza Therapeutics Product and Service

    • Table Atriva Therapeutics Gmbh (Foundation Year, Company Profile and etc.)

    • Table Atriva Therapeutics Gmbh Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Atriva Therapeutics Gmbh Influenza Therapeutics Product and Service

    • Table Daiichi Sankyo Company (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Company Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Company Influenza Therapeutics Product and Service

    • Table Mylan, Inc (Foundation Year, Company Profile and etc.)

    • Table Mylan, Inc Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan, Inc Influenza Therapeutics Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Influenza Therapeutics Product and Service

    • Table Sandoz International GmbH (Novartis AG) (Foundation Year, Company Profile and etc.)

    • Table Sandoz International GmbH (Novartis AG) Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sandoz International GmbH (Novartis AG) Influenza Therapeutics Product and Service

    • Table Sanofi Pasteur SA (Foundation Year, Company Profile and etc.)

    • Table Sanofi Pasteur SA Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Pasteur SA Influenza Therapeutics Product and Service

    • Table Texas Medical Center (Foundation Year, Company Profile and etc.)

    • Table Texas Medical Center Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Texas Medical Center Influenza Therapeutics Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Influenza Therapeutics Product and Service

    • Table Sun Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Sun Pharmaceutical Industries Ltd Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharmaceutical Industries Ltd Influenza Therapeutics Product and Service

    • Table Life Science Austria (LISA) (Foundation Year, Company Profile and etc.)

    • Table Life Science Austria (LISA) Influenza Therapeutics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Life Science Austria (LISA) Influenza Therapeutics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US